[Enhancement of treatment efficacy in experimental plague by the sequential administration of antibiotics]

Insights

Combining rifampicin with ampicillin, azlocillin, or polymyxin significantly improved plague survival in mice. Delayed administration and reduced frequency of these antibiotics further enhanced survival rates compared to rifampicin alone.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Plague remains a significant public health concern, necessitating effective therapeutic strategies.
  • Rifampicin monotherapy at sub-optimal doses offers limited protection against plague.
  • Combination therapy may overcome antibiotic resistance and improve treatment outcomes.

Purpose of the Study:

  • To evaluate the efficacy of combination antibiotic therapy for plague treatment.
  • To assess the impact of delayed administration and reduced dosing frequency on survival rates.

Main Methods:

  • Murine model of plague infection.
  • Administration of rifampicin alone or in combination with ampicillin, azlocillin, or polymyxin.
  • Varying the timing and frequency of antibiotic administration.

Main Results:

  • Combination therapy with ampicillin, azlocillin, or polymyxin, initiated 24 or 96 hours post-infection alongside daily rifampicin, resulted in 80-100% animal survival.
  • Sequential administration of ampicillin, azlocillin, or polymyxin with rifampicin led to a threefold increase in survival compared to rifampicin alone.
  • Decreased administration frequency and increased intervals between doses of the combination drugs significantly improved survival rates.

Conclusions:

  • Combination antibiotic therapy demonstrates superior efficacy in treating plague compared to rifampicin monotherapy.
  • Optimizing the dosing schedule of combination therapy can further enhance survival outcomes in plague treatment.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...